Search

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.respol.2005.09.005 Byline: Markus C. Becker (a), Morten Lillemark (b) Keywords: Marketing; R&D; Cross-functional integration; Innovation management; Pharmaceutical industry Abstract: Integrating marketing and R&D inputs is one of the fundamental challenges in managing innovation. In the pharmaceutical industry, considering its reputed 'technology push' model of innovation, the challenge of integrating marketing and R&D could hardly be greater. Thus, the recent trend among pharmaceutical firms of implementing Marketing/R&D integrating mechanisms calls for upgrading our conceptualization of the innovation process in this industry. It also raises important questions regarding Marketing's contribution in new product development, and how to organize to assure that contribution is leveraged. We use the case of a pharmaceutical firm which recently implemented Marketing/R&D integrating mechanisms to examine Marketing's new roles. We find that the extreme conditions surrounding innovation in the pharmaceutical industry, notably the need to cope with Knightean uncertainty, highlight important contributions of Marketing input in R&D that deserve more attention. We suggest that Marketing's most important contribution under these conditions lies in 'not getting it wrong' rather than 'getting it right,' in setting minimum criteria in project evaluations rather than definite targets, and in refocusing the attention of R&D staff through the very process of providing this input. Given the value of these contributions, modern pharmaceutical firms would indeed be ill advised to think of drug discovery as merely a linear process. Drug development has become an interactive process where the timing, type and impact of Marketing involvement is balanced and managed via certain organizational mechanisms throughout the R&D process, which is an iterative one. Author Affiliation: (a) Centre National de Recherche Scientifique (CNRS), Bureau d'Economie Theorique et Appliquee (BETA), 61 Avenue de la Foret Noire, F-67085 Strasbourg, France (b) Copenhagen Business School, Frederiksberg, Denmark Article History: Received 1 October 2004; Accepted 1 September 2005

A study is conducted on pharmaceutical industry to examine advantages and issues concerned with cross functional integration of marketing and research activities.

The application of virtual simulation tools has had a deep effect on problem-solving and new product development organization. It is argued that a thorough comprehension of these deep impacts is important for employing the tools in the development of innovative products.

The organization of new product development process at FIAT is analyzed from resource-based perspective. The analysis revealed long-term negative effects of outsourcing on the knowledge base despite of the short-term beneficial effects on cost.

When Ross Gelbspan spoke about the aftermath of his recent op-ed in The Boston Globe, his comments provoked deep astonishment. As he put it, his article exploded onto the scene [...]